KREBSBIOPharmaceuticals
Krebs Biochemicals & Industries Limited — Balance Sheet
₹39.75
-6.96%
Krebs Biochemicals & Industries Limited Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Capital Stock | 21.56 Cr | 21.56 Cr | 21.56 Cr | 21.56 Cr | — |
| Common Stock | 21.56 Cr | 21.56 Cr | 21.56 Cr | 21.56 Cr | — |
| Total Liabilities Net Minority Interest | 315.27 Cr | 297.39 Cr | 274.44 Cr | 264.90 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 211.75 Cr | 235.56 Cr | 225.34 Cr | 186.83 Cr | — |
| Other Non Current Liabilities | 45.00 Cr | 45.00 Cr | -1000.00 | 45.00 Cr | — |
| Long Term Debt And Capital Lease Obligation | 161.25 Cr | 228.50 Cr | 218.25 Cr | 177.93 Cr | — |
| Long Term Debt | 161.25 Cr | 183.50 Cr | 173.25 Cr | 132.93 Cr | — |
| Long Term Provisions | 3.06 Cr | 0.49 Cr | 0.31 Cr | 0.30 Cr | — |
| Current Liabilities | 103.53 Cr | 61.83 Cr | 49.10 Cr | 78.06 Cr | — |
| Other Current Liabilities | 15.46 Cr | 17.87 Cr | 12.29 Cr | 14.81 Cr | — |
| Current Debt And Capital Lease Obligation | 50.96 Cr | 10.18 Cr | 10.12 Cr | 10.17 Cr | — |
| Current Debt | 50.96 Cr | 10.18 Cr | 10.12 Cr | 10.17 Cr | — |
| Current Provisions | 0.79 Cr | 0.62 Cr | 0.75 Cr | 1.64 Cr | — |
| Payables | 18.15 Cr | 32.73 Cr | 25.43 Cr | 50.28 Cr | — |
| Accounts Payable | 18.15 Cr | 18.97 Cr | 15.28 Cr | 37.91 Cr | — |
| Total Assets | 169.04 Cr | 178.17 Cr | 174.98 Cr | 189.81 Cr | — |
| Total Non Current Assets | 158.78 Cr | 160.73 Cr | 158.92 Cr | 154.31 Cr | — |
| Other Non Current Assets | 7.13 Cr | -4000.00 | -3000.00 | 1000.00 | — |
| Investmentin Financial Assets | 2.85 Cr | 2.54 Cr | 2.38 Cr | 2.30 Cr | — |
| Goodwill And Other Intangible Assets | 2.32 Cr | 2.50 Cr | 2.69 Cr | 2.87 Cr | — |
| Other Intangible Assets | 2.32 Cr | 2.50 Cr | 2.69 Cr | 2.87 Cr | — |
| Net PPE | 146.47 Cr | 149.74 Cr | 149.05 Cr | 144.93 Cr | — |
| Gross PPE | 146.47 Cr | 310.07 Cr | 302.80 Cr | 292.37 Cr | — |
| Construction In Progress | 1.24 Cr | 0.44 Cr | 2.58 Cr | 7.24 Cr | — |
| Other Properties | 145.23 Cr | 21.85 Cr | 21.43 Cr | 20.43 Cr | — |
| Current Assets | 10.26 Cr | 17.44 Cr | 16.06 Cr | 35.49 Cr | — |
| Other Current Assets | 3.84 Cr | 2.59 Cr | -1000.00 | -2000.00 | — |
| Inventory | 6.03 Cr | 9.80 Cr | 11.95 Cr | 25.56 Cr | — |
| Accounts Receivable | 0.05 Cr | 1.90 Cr | 0.53 Cr | 0.88 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 0.34 Cr | 0.07 Cr | 0.02 Cr | 0.03 Cr | — |
| Ordinary Shares Number | 2.16 Cr | 2.16 Cr | 2.16 Cr | 2.16 Cr | — |
| Share Issued | 2.16 Cr | 2.16 Cr | 2.16 Cr | 2.16 Cr | — |
| Net Debt | 212.07 Cr | 193.61 Cr | 183.35 Cr | 143.07 Cr | — |
| Total Debt | 212.21 Cr | 238.68 Cr | 228.37 Cr | 188.10 Cr | — |
| Tangible Book Value | -148.56 Cr | -121.72 Cr | -102.15 Cr | -77.96 Cr | — |
| Invested Capital | 65.97 Cr | 74.46 Cr | 83.91 Cr | 68.01 Cr | — |
| Working Capital | -93.27 Cr | -44.39 Cr | -33.04 Cr | -42.57 Cr | — |
| Net Tangible Assets | -148.56 Cr | -121.72 Cr | -102.15 Cr | -77.96 Cr | — |
| Common Stock Equity | -146.24 Cr | -119.22 Cr | -99.46 Cr | -75.09 Cr | — |
| Total Capitalization | 15.01 Cr | 64.28 Cr | 73.78 Cr | 57.84 Cr | — |
| Total Equity Gross Minority Interest | -146.24 Cr | -119.22 Cr | -99.46 Cr | -75.09 Cr | — |
| Stockholders Equity | -146.24 Cr | -119.22 Cr | -99.46 Cr | -75.09 Cr | — |
| Other Equity Interest | -167.80 Cr | 0.39 Cr | 0.39 Cr | 0.39 Cr | — |
| Other Short Term Investments | 0.20 Cr | 3.01 Cr | 0.29 Cr | 0.21 Cr | — |
| Cash And Cash Equivalents | 0.14 Cr | 0.07 Cr | 0.02 Cr | 0.03 Cr | — |
| Non Current Pension And Other Postretirement Benefit Plans | — | 3.05 Cr | 2.60 Cr | 2.63 Cr | 2.56 Cr |
| Tradeand Other Payables Non Current | — | 4.01 Cr | 4.50 Cr | 6.27 Cr | 5.65 Cr |
| Long Term Capital Lease Obligation | — | 45.00 Cr | 45.00 Cr | 45.00 Cr | 45.00 Cr |
| Pensionand Other Post Retirement Benefit Plans Current | — | 1.06 Cr | 1.26 Cr | 1.17 Cr | 1.49 Cr |
| Other Payable | — | 13.76 Cr | 10.15 Cr | 12.37 Cr | 8.29 Cr |
| Non Current Prepaid Assets | — | 3.75 Cr | 3.59 Cr | 3.51 Cr | 3.46 Cr |
| Accumulated Depreciation | — | -160.34 Cr | -153.75 Cr | -147.45 Cr | -141.79 Cr |
| Machinery Furniture Equipment | — | 212.06 Cr | 203.73 Cr | 190.59 Cr | 161.58 Cr |
| Buildings And Improvements | — | 27.30 Cr | 26.64 Cr | 25.69 Cr | 22.18 Cr |
| Land And Improvements | — | 48.42 Cr | 48.42 Cr | 48.42 Cr | 48.42 Cr |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 0.07 Cr | 0.07 Cr | 0.07 Cr | 0.12 Cr |
| Prepaid Assets | — | 2.61 Cr | 3.24 Cr | 8.86 Cr | 3.73 Cr |
| Finished Goods | — | 1.51 Cr | 1.31 Cr | 1.65 Cr | 1.39 Cr |
| Work In Process | — | 5.12 Cr | 6.39 Cr | 11.92 Cr | 6.64 Cr |
| Raw Materials | — | 3.17 Cr | 4.25 Cr | 11.99 Cr | 8.57 Cr |
| Other Receivables | — | 2.99 Cr | 0.26 Cr | 0.10 Cr | 0.08 Cr |
| Capital Lease Obligations | — | 45.00 Cr | 45.00 Cr | 45.00 Cr | 45.00 Cr |
| Retained Earnings | — | -270.24 Cr | -250.49 Cr | -226.12 Cr | -181.24 Cr |
| Additional Paid In Capital | — | 118.02 Cr | 118.02 Cr | 118.02 Cr | 103.27 Cr |
| Cash Financial | — | 0.07 Cr | 0.02 Cr | 0.03 Cr | 0.59 Cr |
| Other Inventories | — | — | -1000.00 | -1000.00 | — |
| Preferred Securities Outside Stock Equity | — | — | — | 130.00 Cr | 30.00 Cr |
| Gross Accounts Receivable | — | — | — | 0.88 Cr | 0.30 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Krebs Biochemicals & Industries Limited
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.